Alkermes Plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alkermes Plc with three other
pharmaceutical manufacturers in Europe:
sales of 589.60 million Euro [US$626.57 million]
of which 70%
(488.74 million Euro [US$519.38 million]
of which 43%
was X-rays), and
based in France
(607.80 million Euro [US$645.91 million]
of which 51%
was Non-Proprietary Homeopathic Medicines).
Alkermes Plc reported sales of 569.69 million Euro (US$605.41 million)
December of 2015.
increase of 21.6%
versus 2014, when the company's sales were 468.63 million Euro.
Sales at Alkermes Plc have increased during each of the previous five years
(and since 2010, sales have increased a total of 351%).